Compounds > 1-2-dioleoyloxy-3-(trimethylammonium)propane

1-2-dioleoyloxy-3-(trimethylammonium)propane and 6-methoxy-2-naphthylacetic-acid

1-2-dioleoyloxy-3-(trimethylammonium)propane has been researched along with 6-methoxy-2-naphthylacetic-acid* in 1 studies

Other Studies

1 other study(ies) available for 1-2-dioleoyloxy-3-(trimethylammonium)propane and 6-methoxy-2-naphthylacetic-acid

ArticleYear
Drug-fortified liposomes as carriers for sustained release of NSAIDs: The concept and its validation in the animal model for the treatment of arthritis.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, Dec-01, Volume: 125

    Drug-fortified cationic liposomes of 6‑methoxy‑2‑naphthylacetic acid (6‑MNA) were prepared and characterized by various techniques. The residence time of drug-fortified liposomes in joint cavity was evaluated by intra-articular (IA) administration of the radio-labeled (

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cartilage, Articular; Cell Survival; Delayed-Action Preparations; Fatty Acids, Monounsaturated; Liposomes; Male; Mice; Naphthaleneacetic Acids; NIH 3T3 Cells; Phosphatidylcholines; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Rats, Sprague-Dawley

2018